The distribution of IL-13 receptor alpha1 expression on B cells, T cells and monocytes and its regulation by IL-13 and IL-4. 1998

P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
Geneva Biomedical Research Institute, Plan-les-Ouates, Switzerland.

To study the expression of IL-13 receptor alpha1 (IL-13Ralpha1), specific monoclonal antibodies (mAb) were generated. Surface expression of the IL-13Ralpha1 on B cells, monocytes and T cells was assessed by flow cytometry using these specific mAb. Among tonsillar B cells, the expression was the highest on the IgD+ CD38- B cell subpopulation which is believed to represent naive B cells. Expression was also detectable on a large fraction of the IgD-CD38- B cells but not on CD38+ B cells. Activation under conditions which promote B cell Ig class switching up-regulated the expression of the receptor. However, the same stimuli had an opposite effect for IL-13Ralpha1 expression levels on monocytes. While IL-13Ralpha1 mRNA was clearly detectable in T cell preparations, no surface expression was detected. However, permeabilization of the T cells showed a clear intracellular expression of the receptor. A soluble form of the receptor was immunoprecipitated from the supernatant of activated peripheral T cells, suggesting that T cell IL-13Ralpha1 might have functions unrelated to the capacity to form a type II IL-4/IL-13R with IL-4Ralpha.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015847 Interleukin-4 A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells. B-Cell Growth Factor-I,B-Cell Stimulatory Factor-1,Binetrakin,IL-4,Mast Cell Growth Factor-2,B Cell Stimulatory Factor-1,B-Cell Growth Factor-1,B-Cell Proliferating Factor,B-Cell Stimulating Factor-1,B-Cell Stimulatory Factor 1,BCGF-1,BSF-1,IL4,MCGF-2,B Cell Growth Factor 1,B Cell Growth Factor I,B Cell Proliferating Factor,B Cell Stimulating Factor 1,B Cell Stimulatory Factor 1,Interleukin 4,Mast Cell Growth Factor 2
D053660 Receptors, Interleukin-13 Cell surface receptors for INTERLEUKIN-13. Included under this heading are the INTERLEUKIN-13 RECEPTOR ALPHA2 which is a monomeric receptor and the INTERLEUKIN-4 RECEPTOR TYPE II which has specificity for both INTERLEUKIN-4 and INTERLEUKIN-13. IL-13 Receptors,Interleukin-13 Receptors,IL-13 Receptor,Interleukin-13 Receptor,Receptor, Interleukin-13,IL 13 Receptor,IL 13 Receptors,Interleukin 13 Receptor,Interleukin 13 Receptors,Receptor, IL-13,Receptor, Interleukin 13,Receptors, IL-13,Receptors, Interleukin 13

Related Publications

P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
May 1991, Journal of immunology (Baltimore, Md. : 1950),
P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
April 2002, Immunology letters,
P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
May 2008, Proceedings of the National Academy of Sciences of the United States of America,
P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
August 1993, Cellular immunology,
P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
January 2012, Biochemical and biophysical research communications,
P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
September 2001, Journal of immunology (Baltimore, Md. : 1950),
P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
October 1996, Journal of immunology (Baltimore, Md. : 1950),
P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
June 1990, Journal of immunology (Baltimore, Md. : 1950),
P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
September 1991, Leukemia,
P Graber, and D Gretener, and S Herren, and J P Aubry, and G Elson, and J Poudrier, and S Lecoanet-Henchoz, and S Alouani, and C Losberger, and J Y Bonnefoy, and M H Kosco-Vilbois, and J F Gauchat
January 1989, Cold Spring Harbor symposia on quantitative biology,
Copied contents to your clipboard!